The Value of Ultrasonography Screening Trisomy 21 during the Second and Third Trimesters of Gestation

Abstract:

Objective To investigate the value of ultrasonography screening trisomy 21during the second and third trimesters. Methods Amniocentesis and cordocentesis were performed on 3110 and 187pregnant women respectively with indications for prenatal diagnosis to detect karyotype of the fetus during second trimester and late pregnancy, The detection rate of trisomy 21 was compared in pregnant women of different indications. To analyze the relationship between the ultrasonography abnormalities and trisomy 21. Results In chromosomal karyotypes analysis of 3110 pregnant women by amniocentesis, 41 trisomy 21 were detected, The detection rate of trisomy 21 was 1.32%. There were 98 in 3110 pregnant women with ultrasonography abnormalities, 6 trisomy 21 were found within them and the detection rate was 6.12%, the detection rate of trisomy 21 detected by ultrasound (6.12% ) was higher than the Down^,s syndrome high risk group (0.98%), advanced age group (0.58%) Within 187 pregnant women of chromosomal karyotypes analysis by cordocentesis, 9 trisomy 21 were detected and the detection rate of trisomy 21 was 4.81% . There were 128 in 187 pregnant women with ultrasonography abnormalities, 5 trisomy 21 were found within them and the detection rate of trisomy 21 was 3.91% . (P <0. 05). Conclusions During the second and third trimesters, ultrasonography has great value .

• Periodical: Applied Mechanics and Materials (Volumes 668-669)
• Pages: 1581-1584
• DOI: https://doi.org/10.4028/www.scientific.net/AMM.668-669.1581
• Online since: October 2014
• Authors: Yu Ping Pan*
• Keywords: Amniocentesis, Cordocentesis, Karyotypes Analysis, Trisomy 21, Ultrasonography

References

[1] Boaz Weisz, Pranav P. Pandya, Anna L. David etal. Ultrasound Findings After Screening for Down Syndrome Using the Integrated Test. Obstetrics& Gynecology, 2007, 109: 1046.

DOI: 10.1097/01.aog.0000260234.20190.6e

[2] Karen F, Brian JK·Ultrasound and fetal diagnosis·Curr Opi Obs &Gyn, 2005, 17 (2): 1855.

[3] Vanden H of MC, Wilson RD. Fetal soft markers in Obstetric ultrasound . J Obstet Gynaecol Can, 2005, 27(6): 592-636.

[4] BethuneM·Literature review and suggested protocol formanaging ultrasound softmarkers forDown syndrome: thickened nuchal fold, echogenic bowe, l shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone·AustralasRadio, l 2007, 51 (3): 218.

DOI: 10.1111/j.1440-1673.2007.01713.x

[5] Michiel C. Van den H of MD, Halifax NS R. Douglas Wilson, MD, Philadelphia PA etal. Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Can, 2005, 27 (6): 592.

[6] Benacerruf BR. The role of the second trimester genetic sonogram in screening for fetal Down syndrome[J]. Semin Perinatol, 2005, 29(6): 386－394.

DOI: 10.1053/j.semperi.2005.12.003

[7] Falcon O, Auer M. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks . Ultrasound Obstet Gynecol, 2006, 27(2): 151-155.

DOI: 10.1002/uog.2699